Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-31

Clinical Trial Update: Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity [EARLY_Phase 1]

View source ↗

Summary

This ClinicalTrials.gov entry reports an EARLY Phase 1 study of phentermine/topiramate in adolescents with Type 2 diabetes and obesity, sponsored by the Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Qsymia (phentermine/topiramate extended-release) (phentermine/topiramate extended-release)

Snippet

Sponsor: University of Minnesota | Conditions: Pediatric Obesity | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING